RxDoctor Payments DataLook up a doctor →

Stephen Ansell, MD

Hematology · Rochester, MNNPI 1558335935

Payments from drug & device makers

$5,091,683in general payments, 2019–2025

Across 190 payments — averaging $26,798 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1.3M
  • E.r. Squibb & Sons, L.L.C.$1.1M
  • Pfizer$1.1M
  • Regeneron$590K
  • Seagen Inc.$381K
  • Astrazeneca UK Limited$227K
  • plus $400K from 4 others
$192,295in research payments, 2019–2025

Across 19 payments — averaging $10,121 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orphai Therapeutics Inc.$178K
  • Regeneron$13K
  • Pfizer$1K

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck3$1,347,633
E.r. Squibb & Sons, L.L.C.24$1,074,264
Pfizer14$1,071,663
Regeneron24$590,272
Seagen Inc.69$380,507
Astrazeneca UK Limited6$227,001
ADC Therapeutics America, Inc.7$210,774
Takeda Pharmaceuticals U.S.A., Inc.30$128,359
AstraZeneca7$31,309
Genmab A/s6$29,900

How this compares

$5,091,683 in reported general payments places this provider in the 90th percentile of 111 hematology providers in Minnesota.

See all hematology providers in Minnesota

Medicare billing

Part B allowed, 2024
$149,959
Medicare patients
134
Services billed
11,763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →